Last updated on February 2017

A Phase IIb/III, Randomized, Double-blind, Placebo-controlled Trial of BHV-4157 in Adult Subjects With Spinocerebellar Ataxia


Brief description of study

A Phase IIb/III, Randomized, Double-blind, Placebo-controlled Trial of BHV-4157 in Adult Subjects With Spinocerebellar Ataxia

Detailed Study Description

The purpose of this study is to compare the efficacy of BHV-4157 versus placebo on ataxia symptoms in subjects with spinocerebellar ataxia (SCA).

Clinical Study Identifier: TX147456

Contact Investigators or Research Sites near you

Start Over

Kevin Allison or Mary Freeman

University of South Florida - Morsani Center for Advanced Healthcare
Tampa, FL USA
  Connect »